AzTrials
AzTrials

Laparoscopic Cholecystectomy Surgery Postoperative AnalgesiaNCT07598162

RLB vs ERSP for Postoperative Analgesia in Lap Cholecystectomy

A study testing Retrolaminar Block (RLB) and Erector spinae plane block (ESPB) in people with Laparoscopic Cholecystectomy Surgery Postoperative Analgesia, run by Sohag University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective, randomized, double-blind clinical trial evaluates the comparative effectiveness of ultrasound-guided retrolaminar block (RLB) and erector spinae plane block (ESPB) for postoperative analgesia in patients undergoing laparoscopic cholecystectomy. Read more about this study

Who is it for?
Ages 20 to 60 years
What is being tested?
Retrolaminar Block (RLB) and Erector spinae plane block (ESPB)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteEgypt
Study dates
Apr 2026to 1 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • • Age from 20 to 60 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) grade I and II physical status.
  • Patients will undergo cholecystectomy under general anesthesia.

Who cannot join

  • • Sensitivities or contraindications to the study medications.
  • Infection at the site of injection.
  • Emergency surgery.
  • Body mass index (BMI) > 35.
  • Organic comorbidities.
  • Histories of psychological conditions and/or chronic pain syndromes.
Show all 11Show fewer
  • Contraindications to regional anesthesia.
  • Severe respiratory, cardiac, hepatic and renal disorders.
  • Pregnancy.
  • Coagulopathy.
  • Opioid addiction.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Esraa abdallah Mohamed, resident contact

01066981675

esraa97egy@gmail.com

Egypt1 site
  • Sohag Faculty of Medicine

    Sohag

    Esraa abdallah Mohamed, resident, 01066981675, esraa97egy@gmail.com

Other trials in Egypt

About this study

Official title: Retrolaminar Block Versus Erector Spinae Plane Block for Postoperative Analgesia in Laparoscopic Cholecystectomy: A Comparative Randomized Prospective Study

This prospective, randomized, double-blind clinical trial evaluates the comparative effectiveness of ultrasound-guided retrolaminar block (RLB) and erector spinae plane block (ESPB) for postoperative analgesia in patients undergoing laparoscopic cholecystectomy. A total of 100 ASA I-II patients, aged 20-60 years, will be randomly allocated into two equal groups to receive either RLB or ESPB bilaterally following induction of standardized general anesthesia. The primary outcome is the time to first request for rescue analgesia, while secondary outcomes include total morphine consumption within the first 24 hours, postoperative pain scores assessed using the Numeric Rating Scale (NRS), patient satisfaction, and the incidence of adverse events. Pain assessment will be performed at predefined intervals over the first 24 hours postoperatively. The study aims to determine which technique provides superior analgesia with reduced opioid requirements and improved patient outcomes.

Being tested
Retrolaminar Block (RLB), Erector spinae plane block (ESPB)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Retrolaminar Block (RLB)Biological

    Patients will be positioned laterally, and a curved ultrasound probe will be aligned longitudinally at the T7 vertebra. The vertebral lamina and spinous process will be identified. A needle will be inserted 1 - 1.5 cm lateral to the spinous process, advanced toward the lamina, and 20 mL of LA mixture will be injected into the fascial plane between the lamina and transversus spinae muscles bilaterally.

  • Erector spinae plane block (ESPB)Procedure or surgery

    The blocks will be conducted at the level of the T7 spinous process (SP) with the patient in the lateral position and the arm abducted. Using US ( curved probe ) , the T7 transverse process (TP) is identified by counting from the 12th rib. The US probe is positioned 2 - 3 cm laterally to the SP of T7 and situated over the TP of T7/T8 in the parasagittal longitudinal plane, with the erector spinae muscle (ESM) visualized over the TP. The needle is then inserted and advanced in plane from cephalad to caudad until the needle tip contacts the TP of T7. Following hydro dissection with 2 mL of isotonic saline, which elevates the ESM, 20 mL of LA mixture is administered after several negative aspirations.

Study groups in NCT07598162
Study groupRoleWhat they receive
RLB groupActive comparatorNot described
Receives: Biological: Retrolaminar Block (RLB)
ESPB groupActive comparatorNot described
Receives: Procedure: Erector spinae plane block (ESPB)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to the 1st rescue analgesia

    Measured: in the 1st 24hr.

Secondary outcomes (3)
  1. Total morphine consumption

    Measured: in the 1st 24hr.

  2. Pain score.

    postoperative pain assessment with the Numeric Rating Scale (NRS). Numeric rating scale .. zero represents no pain while 10 represents the worst pain imaginable

    Measured: Pain will be assessed at, 2, 4, 6, 8, 12, 18 and 24 hour postoperatively.

  3. Degree of patient satisfaction

    • Degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1 represents extremely dissatisfied 2 represesnts unsatisfied; 3 represents neutral 4 represents satisfied 5 represents extremely satisfied)

    Measured: in the first 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2026
  2. Study startApr 2026 (estimated)
  3. Primary completionSep 2027 (estimated)
  4. Study completion1 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07598162
Sponsor's protocol ID
soh-Med-26-3-9MS
Status last verified
May 2026
First submitted
1 May 2026
Last updated
20 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Retrolaminar Block (RLB) and Erector spinae plane block (ESPB) in people with Laparoscopic Cholecystectomy Surgery Postoperative Analgesia, run by Sohag University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Esraa abdallah Mohamed, resident (01066981675, esraa97egy@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to the 1st rescue analgesia (time frame: in the 1st 24hr.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in